Releases - Biotage

View:

2007

 

Found press releases

 

Interim report January – September 2007

10/25/2007 2:53 AM EST
• Net sales amounted to 361.9 (382.9) MSEK in the period January – September 2007 and to 111.9 (133.9) MSEK in the third quarter. At comparable exchange rates and excluding the Chem Dev product area, which is being closed down, sales increased by 1% in the nine month period and decreased by 12% in the third quarter.

• The operating result for the first nine months 2007 amounted to 27.6 (-2.9) MSEK. The operating...

Biotage AB Nomination Committee

10/8/2007 8:26 AM EST
A Nomination Committee consisting of shareholder representatives and the Chairman of the Board of Directors has been formed for Biotage AB. The Nomination Committee shall, before the Annual General Meeting 2008, prepare proposals for the election of Chairman and other members of the Board of Directors, the election of auditors, the election of Chairman of the Annual General Meeting, the determination of fees and...

Interim report January – June 2007

8/14/2007 2:57 AM EST
• Net sales in the second quarter amounted to 131.1 MSEK (128.3) and to 250.0 MSEK (249.0) in the period January – June. At comparable exchange rates and excluding the Chem Dev product area which is being closed down sales increased by 8% in both periods.

• The operating result for the second quarter amounted to 11.1 MSEK (-2.2). The operating result for the first six months 2007 amounted to 18.3 MSEK...

Biotage open up new business area – Molecular Imaging

6/19/2007 4:16 AM EST
Molecular Imaging is an emerging market that is playing an important role to the ongoing worldwide efforts at improving health care and cost saving in the Pharma Industry. Biotage entered into a Molecular Imaging collaboration with McMaster University in February 2007 and it has ever since become more and more apparent that Biotage is significantly well positioned to become an important player within this industry....

Resolutions at the Annual General Meeting in Biotage AB on April 26, 2007

4/27/2007 8:54 AM EST
At the Annual General Meeting held in Biotage AB (Reg. No. 556539-3138) on April 26, 2007, the following resolutions were passed, among others.

Appropriation of the company’s result
The General Meeting resolved that the company’s accumulated losses shall be carried forward.

Board of Directors etc.
The General Meeting resolved to re-elect Ove Mattsson, Thomas Eklund, Annika Espander, Staffan Lindstrand,...

Interim report January – March 2007

4/26/2007 8:08 AM EST
• Net sales in the first quarter amounted to 118.9 (120.6) MSEK. At comparable exchange rates sales increased by 5%.

• The operating result for the first quarter amounted to 7.2 (-12.2) MSEK.

• The net result for the first quarter amounted to 7.2 (-20.8) MSEK and the result per share to 0.08 (-0.24) SEK.

• The cash flow from operating activities amounted to 14.2 (-11.6) MSEK.

• Net sales in the last 12...

Biotage AB and Shanghai Chempartner Co., Ltd. sign multi-instrument deal

4/24/2007 3:58 AM EST
Shanghai Chempartner Co., Ltd., one of China’s leading Contract Research Organizations (CRO), has invested in Biotage SP automated flash instruments and Initiator microwave synthesizers with delivery scheduled over the next 12 months. This is Biotages’s largest single order in China at a value of SEK 10m.

Biotage drug discovery instruments and consumables are widely used by medicinal chemists at the world’s...

Notice of Annual General Meeting in Biotage AB

3/23/2007 4:40 AM EST
Shareholders in Biotage AB are hereby invited to attend the Annual General Meeting, to be held on Thursday, April 26, 2007, at 5:00 p.m., at the head office of Biotage AB, Kungsgatan 76 in Uppsala, Sweden.

Notice etc.

Shareholders who wish to participate in the General Meeting must
a) be recorded as a shareholder in the share register maintained by VPC AB on Friday, April 20, 2007, and
b) notify the...

Biotage – Change of security type

3/22/2007 9:49 AM EST
At the Annual General Meeting held on 27 April 2006, the shareholders resolved to adopt new Articles of Association. According to the new Articles of Association, the company shall have only one class of shares and that shall be common shares. Consequently, the company’s A-shares are changed to shares without serial identification. This means that the security type Ak A is changed to Ak in the VPC system. The record...

Proposals for Annual General Meeting

3/21/2007 3:30 AM EST
The Board of Directors of Biotage AB proposes the Annual General Meeting on April 26, 2007, to:
authorize the Board to issue shares and/or convertibles
resolve on the adoption of a global employee stock option program
resolve on a hedging arrangement for the adoption of the employee stock option program (authorization for the Board to issue warrants)
Authorization for the Board to issue shares and/or...

Biotage

Biotage accelerates the drug discovery and development process and increases the knowledge of the importance of the genetic make-up by providing complete solutions for medicinal chemistry research and applied genetic ana...

View more


  CONTACT